![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Active Filter(s):
Details:
The relationship expands Reakiro’s product portfolio from CBD food supplements and cosmetics to include medicinal cannabis products that can be supplied on a prescription basis by pharmacies, clinics, and hospitals globally.
Lead Product(s): Cannabidiol,Tetrahydrocannabinol
Therapeutic Area: Neurology Product Name: Estratt
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: A2W Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership November 21, 2022